4.5 Article

DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage

期刊

NATURE STRUCTURAL & MOLECULAR BIOLOGY
卷 19, 期 11, 页码 1093-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2394

关键词

-

资金

  1. Division of Signal Transduction Therapy Unit
  2. AstraZeneca
  3. Boehringer-Ingelheim
  4. GlaxoSmithKline
  5. Merck KgaA
  6. Janssen Pharmaceutica
  7. Pfizer
  8. Medical Research Council Protein Phosphorylation Unit
  9. Medical Research Council UK
  10. Association for International Cancer Research
  11. Cancer Research UK
  12. Cancer Research UK [11243] Funding Source: researchfish
  13. Medical Research Council [MC_U127070192] Funding Source: researchfish
  14. MRC [MC_U127070192] Funding Source: UKRI

向作者/读者索取更多资源

Ubiquitin-binding domains (UBDs) are crucial for recruiting many proteins to sites of DNA damage. Here we characterize C1orf124 (Spartan; referred to as DVC1), which has an UBZ4-type UBD found predominantly in DNA repair proteins. DVC1 associates with DNA replication factories and localizes to sites of DNA damage in human cells, in a manner that requires the ability of the DVC1 UBZ domain to bind to ubiquitin polymers in vitro and a conserved PCNA-interacting motif. DVC1 interacts with the p97 protein 'segregase'. We show that DVC1 recruits p97 to sites of DNA damage, where we propose that p97 facilitates the extraction of the translesion synthesis (TLS) polymerase (Pol) eta during DNA repair to prevent excessive TLS and limit the incidence of mutations induced by DNA damage. We introduce DVC1 as a regulator of cellular responses to DNA damage that prevents mutations when DNA damage occurs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据